Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology

The ability to select a sensitive patient population may be crucial for the development of a targeted therapy. Identifying such a population with an acceptable level of confidence may lead to an inflation in development time and cost. We present an approach that allows to decrease these costs and to...

Ausführliche Beschreibung